This week's episode features two very different topics. Patrick Chovanec of Silvercrest Asset Management joins Cardiff Garcia and Matt Klein to discuss devaluation of the renminbi and other imbalances in the Chinese economy. FT correspondents Shannon Bond and David Crow examine concerns raised over Flibanserin, the newly approved drug for hypoactive sexual desire disorder.

iTunes Stitcher audioBoom SoundCloud Overcast RSS

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.